Target intelligence / Profile preview

Immune-related cytokine expression

Molecular classification
Other
01

Overview

Immune-related cytokine expression is the biological process by which immune cells, such as macrophages, T-cells, and B-cells, synthesize and release small signaling proteins to regulate the body's defense mechanisms (StatPearls, 2023). These cytokines, including interleukins, interferons, and tumor necrosis factors, act as essential mediators of intercellular communication, influencing cell growth, differentiation, and activation (Nature Reviews Immunology, 2021). While cytokine expression is a phenotypic readout or a physiological process rather than a specific molecular target like a receptor or enzyme, it is a primary focus of pharmacological modulation in various therapeutic areas. Dysregulation of this process, characterized by the overproduction of pro-inflammatory cytokines, is a central driver of autoimmune diseases, chronic inflammatory conditions, and life-threatening cytokine storms (Frontiers in Immunology, 2020). Drugs such as corticosteroids, JAK inhibitors, and various biologics work by intervening in the signaling pathways or transcriptional machinery that govern the expression of these mediators. Consequently, monitoring cytokine levels serves as a vital tool for assessing disease activity and the efficacy of immunomodulatory therapies (PubMed, 2022). This process is highly dynamic and context-dependent, requiring precise therapeutic control to avoid excessive immunosuppression.

Other names
Cytokine productionCytokine secretionInflammatory cytokine profileCytokine synthesis
02

Mechanism of action

Modulation of intracellular signaling pathways (e.g., JAK/STAT, NF-κB) and transcriptional regulation to decrease the production of pro-inflammatory cytokines or increase anti-inflammatory mediators.

03

Biological functions

Immune responseInflammationSignal transductionCell differentiation
04

Disease associations

InflammationCancerInfectionAutoimmune diseaseCytokine release syndrome
05

Safety considerations

Increased risk of opportunistic infectionsReactivation of latent tuberculosisNeutropeniaPotential for malignancy with long-term use
06

Interacting drugs

Dexamethasone

5 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)C-reactive protein (CRP)Interferon-gamma (IFN-γ)

Beyond the preview

Go deeper on Immune-related cytokine expression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune-related cytokine expression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call